ORIC: the balance sheet

MyFinsight

Oric Pharmaceuticals, Inc. (ORIC)

Balance Sheets	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Cash and cash equivalents	56,396	45,669	49,668	75,864
Short-term investments	225,536	235,819	237,472	206,649
Prepaid expenses and other current assets	8,301	6,978	8,454	8,611
Total current assets	290,233	288,466	295,594	291,124
Long-term investments	137,779	110,762	125,908	45,216
Total property and equipment, gross	10,068	10,066	10,720	NaN
Less accumulated depreciation	7,921	7,651	8,161	NaN
Property and equipment, net	2,147	2,415	2,559	2,762
Other assets	6,603	7,247	7,131	7,755
Total assets	436,762	408,890	431,192	346,857

Accounts payable	2,895	3,824	2,900	3,130
Accrued liabilities	14,876	16,593	17,279	14,920
Total current liabilities	17,771	20,417	20,179	18,050
Other long-term liabilities	3,434	4,111	4,094	4,812
Total liabilities	21,205	24,528	24,273	22,862
Common stock, 0.0001 par value 1,000,000,000 shares authorized 103,486,412 and 98,528,949 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively	11	11	11	9
Additional paid-in capital	1,143,845	1,075,807	1,068,030	952,949
Accumulated deficit	-728,009	-692,242	-661,737	-629,150
Accumulated other comprehensive (loss) income	-290	786	615	187
Total stockholders' equity	415,557	384,362	406,919	323,995
Total liabilities and stockholders' equity	436,762	408,890	431,192	346,857

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.